Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are shared breast cancer biomarkers, and the classification of breast cancer is mostly centered on them. This evidence concerns the gene ERBB2 and breast carcinoma.